Wolverine Trading’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $2.77M | Buy |
+18,700
| New | +$2.83M | ﹤0.01% | 1892 |
|
|
2025
Q2 | – | Sell |
-40,650
| Closed | -$6M | – | 4735 |
|
|
2025
Q1 | $6M | Buy |
40,650
+20,100
| +98% | +$2.91M | 0.01% | 891 |
|
|
2024
Q4 | $2.69M | Sell |
20,550
-3,600
| -15% | -$504K | ﹤0.01% | 1713 |
|
|
2024
Q3 | $3.75M | Buy |
24,150
+5,650
| +31% | +$912K | ﹤0.01% | 1244 |
|
|
2024
Q2 | $2.89M | Sell |
18,500
-4,050
| -18% | -$609K | ﹤0.01% | 1342 |
|
|
2024
Q1 | $3.06M | Buy |
22,550
+450
| +2% | +$59.6K | ﹤0.01% | 1315 |
|
|
2023
Q4 | $2.98M | Sell |
22,100
-58,350
| -73% | -$7.59M | ﹤0.01% | 1410 |
|
|
2023
Q3 | $10.9M | Buy |
80,450
+21,900
| +37% | +$2.99M | 0.01% | 593 |
|
|
2023
Q2 | $8.3M | Buy |
58,550
+12,500
| +27% | +$1.84M | 0.01% | 670 |
|
|
2023
Q1 | $6.37M | Sell |
46,050
-2,650
| -5% | -$357K | 0.01% | 718 |
|
|
2022
Q4 | $6.6M | Buy |
48,700
+6,950
| +17% | +$872K | 0.01% | 760 |
|
|
2022
Q3 | $4.58M | Buy |
41,750
+12,550
| +43% | +$1.59M | 0.01% | 894 |
|
|
2022
Q2 | $3.91M | Sell |
29,200
-12,250
| -30% | -$1.61M | 0.01% | 922 |
|
|
2022
Q1 | $5.56M | Buy |
+41,450
| New | +$4.97M | 0.01% | 1011 |
|
|
2021
Q4 | – | Sell |
-67,050
| Closed | -$8M | – | 5800 |
|
|
2021
Q3 | $8M | Buy |
+67,050
| New | +$7.81M | 0.01% | 956 |
|
|
2021
Q2 | – | Sell |
-44,550
| Closed | -$4.45M | – | 5940 |
|
|
2021
Q1 | $4.45M | Sell |
44,550
-7,500
| -14% | -$754K | 0.01% | 1221 |
|
|
2020
Q4 | $5.22M | Buy |
52,050
+6,150
| +13% | +$651K | 0.01% | 1028 |
|
|
2020
Q3 | $5.06M | Buy |
45,900
+16,450
| +56% | +$1.83M | 0.01% | 855 |
|
|
2020
Q2 | $3.12M | Sell |
29,450
-6,300
| -18% | -$651K | 0.01% | 1096 |
|
|
2020
Q1 | $3.18M | Buy |
35,750
+15,900
| +80% | +$1.5M | 0.01% | 1015 |
|
|
2019
Q4 | $1.99M | Buy |
19,850
+1,200
| +6% | +$113K | ﹤0.01% | 1840 |
|
|
2019
Q3 | $1.69M | Sell |
18,650
-32,300
| -63% | -$2.8M | ﹤0.01% | 1554 |
|
|
2019
Q2 | $4.21M | Buy |
+50,950
| New | +$3.99M | 0.01% | 1005 |
|
|
2019
Q1 | – | Sell |
-20,150
| Closed | -$1.52M | – | 4503 |
|
|
2018
Q4 | $1.52M | Sell |
20,150
-1,950
| -9% | -$152K | ﹤0.01% | 1636 |
|
|
2018
Q3 | $1.75M | Sell |
22,100
-10,600
| -32% | -$802K | ﹤0.01% | 1804 |
|
|
2018
Q2 | $2.29M | Hold |
32,700
| – | – | 0.01% | 1481 |
|
|
2018
Q1 | $2.29M | Buy |
+32,700
| New | +$2.27M | 0.01% | 1481 |
|
|
2017
Q4 | – | Sell |
-33,600
| Closed | -$2.28M | – | 4875 |
|
|
2017
Q3 | $2.28M | Sell |
33,600
-5,100
| -13% | -$322K | 0.01% | 1243 |
|
|
2017
Q2 | $2.64M | Buy |
38,700
+10,900
| +39% | +$712K | 0.01% | 1053 |
|
|
2017
Q1 | $1.73M | Buy |
27,800
+6,150
| +28% | +$358K | 0.01% | 1285 |
|
|
2016
Q4 | $1.18M | Buy |
21,650
+8,900
| +70% | +$505K | 0.01% | 1759 |
|
|
2016
Q3 | $843K | Buy |
+12,750
| New | +$833K | ﹤0.01% | 2052 |
|
Other funds holding AZN
Wolverine Trading's AZN Position: Q3 2025 in Review
Wolverine Trading opened a new position in AstraZeneca (AZN) in Q3 2025: 8,596 shares worth $1.27M. The stake represents ﹤0.01% of the portfolio and ranks #2644 among its holdings. This is a return to the name: Wolverine Trading previously reported a position in AZN as recently as Q1 2025.
Wolverine Trading first reported a position in AZN in Q4 2016 and has held it in 26 quarters since. The position peaked at $5.47M in Q1 2025. 1,287 funds tracked by Wall St. Rank hold AZN as of Q3 2025.
- Wolverine Trading held 8,596 shares of AstraZeneca worth $1.27M as of Q3 2025.
- AstraZeneca was a new Wolverine Trading position in Q3 2025.
- AstraZeneca made up ﹤0.01% of Wolverine Trading's portfolio in Q3 2025, its #2644 holding.
- Wolverine Trading first reported a position in AstraZeneca in Q4 2016 and has held it in 26 quarters since.
- Wolverine Trading's AstraZeneca position peaked at $5.47M in Q1 2025.
- 1,287 funds tracked by Wall St. Rank held AstraZeneca as of Q3 2025.
Based on Wolverine Trading's 13F filing for Q3 2025, filed 14 Nov 2025.